NASDAQ:CGEM

Cullinan Oncology News Headlines

$29.87
-2.43 (-7.52 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$29.14
Now: $29.87
$32.34
50-Day Range
$32.30
MA: $42.40
$53.42
52-Week Range
$27.01
Now: $29.87
$59.85
Volume194,625 shs
Average Volume292,105 shs
Market Capitalization$1.30 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Cullinan Oncology (NASDAQ CGEM) News Headlines Today

SourceHeadline
Cullinan Oncology (NASDAQ:CGEM) Shares Gap Down to $34.18Cullinan Oncology (NASDAQ:CGEM) Shares Gap Down to $34.18
americanbankingnews.com - April 12 at 11:30 AM
Cullinan Management (NASDAQ:CGEM) Sees Strong Trading VolumeCullinan Management (NASDAQ:CGEM) Sees Strong Trading Volume
americanbankingnews.com - April 8 at 11:50 AM
Are Insiders Buying Cullinan Oncology, Inc. (NASDAQ:CGEM) Stock?Are Insiders Buying Cullinan Oncology, Inc. (NASDAQ:CGEM) Stock?
finance.yahoo.com - April 8 at 7:56 AM
Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare ConferenceCullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 7 at 2:33 PM
Cullinan Management (NASDAQ:CGEM) Trading 4.1% Higher Cullinan Management (NASDAQ:CGEM) Trading 4.1% Higher
americanbankingnews.com - April 7 at 12:32 PM
Cullinan Management (NASDAQ:CGEM) Trading Down 6.2%Cullinan Management (NASDAQ:CGEM) Trading Down 6.2%
americanbankingnews.com - April 6 at 1:26 PM
Cullinan Management (NASDAQ:CGEM) Shares Gap Down to $41.25Cullinan Management (NASDAQ:CGEM) Shares Gap Down to $41.25
americanbankingnews.com - April 5 at 1:16 PM
SVB Leerink Equities Analysts Boost Earnings Estimates for Cullinan Management, Inc. (NASDAQ:CGEM)SVB Leerink Equities Analysts Boost Earnings Estimates for Cullinan Management, Inc. (NASDAQ:CGEM)
americanbankingnews.com - April 2 at 8:18 AM
HC Wainwright Increases Cullinan Management (NASDAQ:CGEM) Price Target to $48.00HC Wainwright Increases Cullinan Management (NASDAQ:CGEM) Price Target to $48.00
americanbankingnews.com - March 30 at 2:30 PM
CGEM Crosses Above Average Analyst TargetCGEM Crosses Above Average Analyst Target
nasdaq.com - March 2 at 3:22 PM
Cullinan Oncology, Inc. to Participate in the H.C. Wainwright Global Life Sciences ConferenceCullinan Oncology, Inc. to Participate in the H.C. Wainwright Global Life Sciences Conference
finance.yahoo.com - March 2 at 3:22 PM
Cullinan Management, Inc. Announces Business UpdateCullinan Management, Inc. Announces Business Update
finance.yahoo.com - February 22 at 9:52 AM
Friday 1/15 Insider Buying Report: TPL, CGEMFriday 1/15 Insider Buying Report: TPL, CGEM
nasdaq.com - January 15 at 10:46 PM
Cullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesCullinan Management Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
markets.businessinsider.com - January 13 at 2:57 AM
This page was last updated on 4/12/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.